Company intelligence / Profile preview

K2 Global

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

K2 Global is a private venture capital firm founded in 2015 with roots in Singapore and Silicon Valley. The firm invests from seed through growth stages in internet, software, and technology-enabled companies across geographies and sectors. Public descriptions of the firm emphasize broad technology investing rather than operation as a biotechnology, pharmaceutical, or healthcare company. While some portfolio companies may touch healthcare or life sciences, K2 Global itself appears to be an investor rather than a drug developer, services provider, or healthcare operating company.

Industry: Investors

Beyond the preview

Go deeper on K2 Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on K2 Global.

Explore the full profile